Health Biotchnology Portfolio Fund Quote

SBHIX Fund  USD 24.42  0.20  0.83%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 21

 
High
 
Low
Low
Health Biotchnology is trading at 24.42 as of the 25th of November 2024; that is 0.83 percent increase since the beginning of the trading day. The fund's open price was 24.22. Health Biotchnology has about a 21 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Health Biotchnology Portfolio are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of December 2022 and ending today, the 25th of November 2024. Click here to learn more.
The fund will normally invest at least 80 percent of its total assets in equity securities of U.S. and foreign healthcare companies and biotechnology companies, regardless of their stock market value . Equity securities include common stocks, preferred stocks, securities convertible into common stocks and warrants. More on Health Biotchnology Portfolio

Moving against Health Mutual Fund

  0.56SFPCX Financial ServicesPairCorr
  0.5STPAX Technology CommunicationsPairCorr
  0.49STPCX Technology CommunicationsPairCorr
  0.46SABIX Aggressive BalancedPairCorr
  0.44SABAX Salient Alternative BetaPairCorr
  0.44SAMAX Moderately AggressivePairCorr

Health Mutual Fund Highlights

Thematic IdeaHealthcare Funds (View all Themes)
Fund ConcentrationSaratoga Funds, Large Value Funds, Health Funds, Healthcare Funds, Health, Saratoga, Large Value, Health (View all Sectors)
Update Date30th of September 2024
Expense Ratio Date28th of December 2022
Fiscal Year EndAugust
Health Biotchnology Portfolio [SBHIX] is traded in USA and was established 25th of November 2024. Health Biotchnology is listed under Saratoga category by Fama And French industry classification. The fund is listed under Health category and is part of Saratoga family. The entity is thematically classified as Healthcare Funds. This fund at this time has accumulated 11.88 M in assets with no minimum investment requirementsHealth Biotchnology is currently producing year-to-date (YTD) return of 6.53%, while the total return for the last 3 years was 4.14%.
Check Health Biotchnology Probability Of Bankruptcy

Instrument Allocation

Top Health Biotchnology Portfolio Mutual Fund Constituents

OMIOwens MinorStockHealth Care
JNJJohnson JohnsonStockHealth Care
DVADaVita HealthCare PartnersStockHealth Care
ILMNIlluminaStockHealth Care
WATWatersStockHealth Care
UTHRUnited TherapeuticsStockHealth Care
UNHUnitedHealth Group IncorporatedStockHealth Care
SYKStrykerStockHealth Care
More Details

Health Biotchnology Top Holders

SAMIXModerately Aggressive BalancedMutual FundAllocation--50% to 70% Equity
SABAXSalient Alternative BetaMutual FundAllocation--70% to 85% Equity
SAMCXSalient Mlp FundMutual FundAllocation--50% to 70% Equity
SABCXSalient Alternative BetaMutual FundAllocation--70% to 85% Equity
SABIXAggressive Balanced AllocationMutual FundAllocation--70% to 85% Equity
SAMAXModerately Aggressive BalancedMutual FundAllocation--50% to 70% Equity
More Details

Health Biotchnology Risk Profiles

Health Biotchnology Against Markets

Other Information on Investing in Health Mutual Fund

Health Biotchnology financial ratios help investors to determine whether Health Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Health with respect to the benefits of owning Health Biotchnology security.
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk